Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Gene Silencing Market Poised To Hit $12.09 Billion By 2030 With A 12.6% CAGR
The gene silencing market has shown rapid expansion in recent years. It is expected to grow from $6.69 billion in 2025 to $7.53 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. This historical growth can be linked to advancements in molecular biology research, the identification of RNA interference mechanisms, increased academic research funding, a rise in genetic disease studies, and greater pharmaceutical research and development spending.
The gene silencing market is projected to experience substantial expansion over the coming years, reaching $12.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. This growth anticipated during the forecast period is primarily driven by factors such as the expansion of gene therapy pipelines, an increasing need for targeted therapeutics, the broadening scope of CRISPR applications, intensified clinical trial activity, and advancements in next-generation gene editing tools. Key trends emerging in this period encompass the growing integration of RNA interference technologies, a greater reliance on CRISPR-based gene silencing techniques, the broadened application of therapeutic gene targeting, an elevated emphasis on precision medicine applications, and enhanced investment in genetic research.
Get A Free Sample Report With In-Depth Market Insights:
Gene Silencing Market Demand Drivers Opening New Revenue Streams
The anticipated expansion of the gene silencing market is linked to an increase in genetic disorder cases moving forward. These conditions are defined by irregularities found within an individual’s DNA, with their detection becoming more frequent, driven by advancements in diagnostics, greater public understanding, and wider availability of genetic screening. The increase in genetic disorders stems from parents having children later in life, which heightens the likelihood of genetic mutations transferring to their descendants. Gene silencing presents a hopeful method for managing genetic disorders, operating by precisely deactivating the expression of defective or pathogenic genes. As an illustration, data from August 2023, provided by the UK-based charity Down Syndrome UK, indicates that approximately 40,000 people in the UK are impacted by Down syndrome, with roughly 1 in every 800 babies born with the condition. Consequently, the growing occurrence of genetic disorders is a key factor propelling the expansion of the gene silencing market.
Gene Silencing Market Segment Trends And Revenue Contributors
The gene silencing market covered in this report is segmented –
1) By Type: Transcriptional, Post-Transcriptional, Meiotic
2) By Gene Silencing: RNA Interference (RNAi), Antisense Oligonucleotides (ASOs), Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing, Other Gene Silencings
3) By Application: Neurology, Oncology, Infectious Diseases, Metabolic Diseases, Therapeutics Manufacturing, Other Applications
4) By End-Users: Pharmaceutical And Biotechnology Companies, Research Institutes and Academic Centers, Hospitals, Clinics, Other End-Users
Subsegments:
1) By Transcriptional: DNA Methylation, Histone Modification
2) By Post-Transcriptional: RNA Interference (RNAi), Antisense Oligonucleotides, MicroRNA (miRNA) Mediated Silencing
3) By Meiotic: Meiotic Gene Conversion, Transposable Element Silencing
Gene Silencing Market Trends Powering Strategic Industry Growth
Leading companies in the gene silencing market are prioritizing the development of innovative technologies, such as small interfering RNA (siRNA), to enhance precision and efficacy within gene therapy. Small interfering RNA (siRNA) is defined as a specific type of RNA molecule that plays a vital role in the RNA interference (RNAi) pathway by attaching to particular messenger RNA (mRNA) and promoting its degradation, thereby preventing the creation of disease-causing proteins. For example, in October 2024, Judo Bio Inc., a US-based biotechnology company, launched siRNA, a next-generation medication that employs small interfering RNA (siRNA) to silence genes. Its unique attributes include proprietary delivery systems like lipid nanoparticles or conjugated ligands, which ensure efficient uptake by specific cells or tissues, and AI-driven platforms that accelerate the identification of viable gene targets.
Gene Silencing Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the gene silencing market are Roche Holding AG, Merck & Co. Inc., AstraZeneca plc, Novartis International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Alnylam Pharmaceuticals Inc., GenScript Biotech Corporation, Oxford BioMedica plc, Ionis Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., New England Biolabs Inc., Quark Pharmaceuticals Inc., Sirion Biotech GmbH, Benitec Biopharma Limited, GeneCopoeia Inc., Revvity Inc.
View The Full Gene Silencing Market Report:
Gene Silencing Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the gene silencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene silencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model